Syros Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Syros Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Syros Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.04M, a 2.98% increase year-over-year.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $4.05M, a 2.87% increase from 2022.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $3.94M, a 2.93% increase from 2021.
  • Syros Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $3.82M, a 22.5% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.05M +$113K +2.87% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $3.94M +$112K +2.93% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $3.82M +$701K +22.5% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 $3.12M +$1.78M +132% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-04
2019 $1.35M Jan 1, 2019 Dec 31, 2019 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.